BSE filing, NSE: SUBEXLTD. Summary written from the filing by ALFA Finder's alert engine.
Subex Ltd: key numbers
- Share price
- ₹17.19
- Market cap
- ₹966.1 Cr
- Revenue (annual)
- ₹279.1 Cr
- Net profit (annual)
- ₹28.53 Cr
- P/E (TTM)
- 32.3×Sector 22.9×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 1.08%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Subex Ltd
All →Subex Board Meeting Date
Subex Ltd scheduled its board meeting for November 3, 2026, to consider Q2 FY27 financial results. An earnings call is set for November 4, 2026, at 11:00 AM IST.
Subex Bags ₹6.72 Cr Order from A leading African mobile operator
Subex won a 3-year, USD 0.7 million contract from a leading African operator for HyperSense Fraud Management deployment. It extends Subex's presence in Africa.
- Value
- ₹6.72 Cr
- From
- A leading African mobile operator (unnamed)
- Execution
- 3 years
Subex Other Announcement
The company submitted its quarterly shareholding pattern statement for the period ending September 30, 2026, as required under SEBI regulations.
Subex Bags ₹47.5 Cr Order from A major mobile network operator in the Asia Pacific region
Subex won a US$5 million (₹47.50 Crore) PEM contract from a major APAC telco. The 5-year deployment expands Subex's partner ecosystem management footprint.
- Value
- ₹47.50 Cr
- From
- A major mobile network operator in the Asia Pacific region (unnamed)
- Execution
- 5 years (with option to extend for additional 2 years)
Subex Annual General Meeting
Subex shareholders approved a new ESOP scheme and related resolutions via postal ballot, as disclosed in the voting results and Scrutinizer's Report.
Subex Bags ₹6.01 Cr Order
Subex Ltd secured a 3-year contract worth approximately ₹6.01 Crore from a leading African mobile operator. The engagement involves deploying HyperSense Fraud Management solutions.
- Value
- ₹6.01 Cr
- Execution
- 3 years
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.